EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
169 hedge funds and large institutions have $947M invested in Eagle Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 37 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
-6
Holders Change %
-3.43%
% of All Funds
4.22%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
34
Increased
80
Reduced
37
Closed
36
Calls
$7.68M
Puts
$5.85M
Net Calls
+$1.83M
Net Calls Change
-$5.84M